InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Michael Secora, Chief Financial Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 34 open-market SEC Form 4 transactions: 0 purchases worth $0 and 34 sales worth $6.2M, reported from Jun 13, 23 to Nov 13, 24. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 13, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 15.0K | $7.66 | $115K |
| Nov 12, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 15.0K | $7.64 | $115K |
| Oct 9, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 15.0K | $6.36 | $95K |
| Oct 8, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 15.0K | $6.32 | $95K |
| Sep 11, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 15.0K | $6.32 | $95K |
| Sep 10, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 15.0K | $6.17 | $93K |
| Aug 14, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 15.0K | $6.35 | $95K |
| Aug 13, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 15.0K | $6.35 | $95K |
| Jul 10, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 15.0K | $7.24 | $109K |
| Jul 9, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 15.0K | $7.32 | $110K |
| Jun 14, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 15.0K | $9.27 | $139K |
| Jun 13, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 15.0K | $9.32 | $140K |
| Apr 17, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 23.1K | $7.58 | $175K |
| Apr 16, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $7.67 | $192K |
| Mar 13, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $11.03 | $276K |
| Mar 12, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $10.46 | $262K |
| Feb 14, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 23.9K | $10.98 | $250K |
| Feb 13, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $9.86 | $247K |
| Jan 17, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $10.25 | $256K |
| Jan 16, 24 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $10.45 | $261K |
| Dec 13, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $7.59 | $190K |
| Dec 12, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $7.39 | $185K |
| Nov 15, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 20.3K | $7.62 | $147K |
| Nov 14, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $6.32 | $158K |
| Oct 11, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $6.85 | $171K |
| Oct 10, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $7.07 | $177K |
| Sep 13, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $8.69 | $217K |
| Sep 12, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $8.43 | $211K |
| Aug 16, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $8.90 | $223K |
| Aug 15, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $9.27 | $232K |
| Jul 19, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 13.2K | $16.00 | $202K |
| Jul 18, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 24.5K | $14.05 | $334K |
| Jun 14, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $10.07 | $252K |
| Jun 13, 23 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 25.0K | $9.93 | $248K |